DavidFrancisGuerrieriMD

Emergency Medicine • Los Angeles, CA

Physician

Join to view full profile

Are you Dr. Guerrieri?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 27 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
4060 E Whittier Blvd
Los Angeles, CA 90023
Phone+1 323-268-5514

Fax+1 626-447-6057
Is this information wrong?

Summary

Dr. David Guerrieri, MD is an emergency medicine physician in Los Angeles, California. He is currently licensed to practice medicine in California, Maryland, and Hawaii.

Education & Training

University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 1977 - 1979
University of Southern California/LAC+USC Medical CenterInternship, Internal Medicine, 1976 - 1977
Virginia Commonwealth University School of MedicineClass of 1976

Certifications & Licensure

AZ State Medical License 1982 - Present
CA State Medical License 1977 - 2023
HI State Medical License 1989 - 2004
MD State Medical License 1998 - 1998

Publications & Presentations

PubMed

Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase.
Cardinale, D., Guaitoli, G., Tondi, D., Luciani, R., Henrich, S., Salo-Ahen, O. M., Ferrari, S., Marverti, G., Guerrieri, D., Ligabue, A., Frassineti, C., Pozzi, C., M...> ;Proc Natl Acad Sci U S A. 2011 Aug 23
Ligand-based virtual screening and ADME-tox guided approach to identify triazolo-quinoxalines as folate cycle inhibitors.
Carosati, E., Sforna, G., Pippi, M., Marverti, G., Ligabue, A., Guerrieri, D., Piras, S., Guaitoli, G., Luciani, R., Costi, M. P., Cruciani, G.> ;Bioorg Med Chem. 2010 Nov 15
Spermidine/spermine N1-acetyltranferase modulation by novel folate cycle inhibitors in cisplatin-sensitive and -resistant human ovarian cancer cell lines.
Marverti, G., Ligabue, A., Guerrieri, D., Paglietti, G., Piras, S., Costi, M. P., Farina, D., Frassineti, C., Monti, M. G., Moruzzi, M. S.> ;Gynecol Oncol. 2010 May
Characterization of the cell growth inhibitory effects of a novel DNA-intercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and -resistant human ovari...
Marverti, G., Ligabue, A., Montanari, M., Guerrieri, D., Cusumano, M., Di Pietro, M. L., Troiano, L., Di Vono, E., Iotti, S., Farruggia, G., Wolf, F., Monti, M. G., Fr...> ;Invest New Drugs. 2011 Feb 01
Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells.
Marverti, G., Ligabue, A., Paglietti, G., Corona, P., Piras, S., Vitale, G., Guerrieri, D., Luciani, R., Costi, M. P., Frassineti, C., Moruzzi, M. S.> ;Eur J Pharmacol. 2009 Aug 01
Join now to see all